drugset / Press release
Grit Bio （沙砾生物） Receives NMPA’s IND Approval for GT101
2022-11-11 · Grit Biotechnology · original gritbio.com ↗
April 22, 2022, Investigational New Drug (IND) Application of Grit Bio’s GT101 has been approved by National Medical Products Administration (NMPA) (acceptance number: CXSL2200061).
The release as fetched from its publisher. gritbio.com ↗